(Q46703467)

24 December 2017

title

Preliminary evidence for gender-specific effects of topiramate as a potential aid to smoking cessation (English)

1 reference

24 December 2017

3

Susan L McElroy

1 reference

24 December 2017

Paul E. Keck

series ordinal

4

object named as

Paul E Keck

1 reference

24 December 2017

Thomas J Blom

series ordinal

2

object named as

Thomas J Blom

1 reference

24 December 2017

Robert M Anthenelli

series ordinal

1

object named as

Robert M Anthenelli

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 April 2008

1 reference

24 December 2017

published in

Addiction

1 reference

24 December 2017

volume

103

1 reference

24 December 2017

issue

4

1 reference

24 December 2017

page(s)

687-694

1 reference

24 December 2017

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02148.X

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02148.X

Prevention of relapse after quitting smoking: a systematic review of trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02148.X

Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02148.X

Weight change after smoking cessation using variable doses of transdermal nicotine replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02148.X

The new antiepileptic drugs: scientific review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02148.X

Topiramate protects against glutamate- and kainate-induced neurotoxicity in primary neuronal–astroglial cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02148.X

Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02148.X

Topiramate-induced neuromodulation of cortico-mesolimbic dopamine function: a new vista for the treatment of comorbid alcohol and nicotine dependence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02148.X

Expanding treatment of tobacco dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02148.X

Topiramate selectively attenuates nicotine-induced increases in monoamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02148.X

Topiramate for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02148.X

Use of oral topiramate to promote smoking abstinence among alcohol-dependent smokers: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02148.X

Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02148.X

Are there sex differences in transdermal nicotine replacement therapy patch efficacy? A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02148.X

Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: differences between men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02148.X

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02148.X

Signs and symptoms of tobacco withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02148.X

Comment on Shiffman and colleagues, "Nicotine patch and lozenge are effective for women".

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02148.X

Sex, GABA, and nicotine: the impact of smoking on cortical GABA levels across the menstrual cycle as measured with proton magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02148.X

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02148.X

Measures of abstinence in clinical trials: issues and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02148.X

10.1111/J.1360-0443.2008.02148.X

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

release_6lj2e3qfqfbodfhid5jpxru4fm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6lj2e3qfqfbodfhid5jpxru4fm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

24 December 2017